SCHEMBL18668619

SCHEMBL18668619

O=C(O)NCCCCCCC1CCc2cc(Cl)ccc2N1

nearest known ligand 0.38

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 2/20 0.38
▸ DRD4 P21917 1/20 0.38
▸ MTNR1A P48039 2/20 0.37
▸ RIPK1 Q13546 4/20 0.36
▸ HTR1A P08908 4/20 0.36
▸ HTR2A P28223 4/20 0.36
▸ DRD3 P35462 4/20 0.36
▸ FFAR4 Q5NUL3 1/20 0.36
▸ HTR2C P28335 2/20 0.35
▸ ADAMTS5 Q9UNA0 2/20 0.35
▸ SRD5A1 P18405 1/20 0.34
▸ GRIN2B Q13224 1/20 0.34
▸ ADAMTS4 O75173 1/20 0.34
▸ NAMPT P43490 2/20 0.33
▸ CNR1 P21554 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18668659 0.88 MTNR1A (0.38) DRD2DRD4MTNR1A
SCHEMBL18668682 0.83 MTNR1A (0.54) DRD2MTNR1AHTR1AHTR2ADRD3
SCHEMBL18668712 0.82 MTNR1A (0.36) DRD2DRD4MTNR1ARIPK1HTR1A
SCHEMBL18668651 0.79 ESR1 (0.34) DRD4HTR2AFFAR4HTR2CSRD5A1
SCHEMBL4763545 0.76 ITGB3 (0.40) MTNR1ARIPK1FFAR4SRD5A1GRIN2B
SCHEMBL6194447 0.73 TRPM5 (0.43) MTNR1AHTR2AHTR2CSRD5A1
SCHEMBL18668649 0.71 MTNR1A (0.54) DRD2MTNR1AHTR1AHTR2ADRD3
SCHEMBL7171518 0.71 NAMPT (0.37) MTNR1AHTR1AHTR2ADRD3GRIN2B
SCHEMBL10841342 0.70 AR (0.43) DRD4MTNR1AHTR2AHTR2CSRD5A1
SCHEMBL6196313 0.70 ESR1 (0.39) DRD4MTNR1AHTR2AFFAR4HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017053360-A1 BICYCLIC AND TRICYCLIC CAP BEARING MERCAPTOACETAMIDE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2017-03-30 — — WO disclosed
Send feedback